PharmaShots | Incisive News in 3 Shots

Subscribe Now

First Home Subcutaneous Treatment

Roche's Enspryng Receives EC's Approval as First Home Subcutaneous Treatment for NMOSD

Roche's Enspryng Receives EC's Approval as First Home Subcutaneous Treatment for NMOSD

June 28, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us